This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Noted Geneticist Dr. Gail E. Herman Is Elected President Of The American College Of Medical Genetics And Genomics (ACMG)





BETHESDA, Md., March 28, 2013 /PRNewswire-USNewswire/ -- Gail E. Herman, MD, PhD, FACMG of Columbus, Ohio, is the new president of the American College of Medical Genetics and Genomics (ACMG), the national professional organization for clinical genetics professionals.

Dr. Herman takes over from Wayne W. Grody, MD, PhD, of Los Angeles, Calif., who completed his two-year term at the 2013 Annual Clinical Genetics Meeting in Phoenix, AZ, in March.

"I've been doing clinical genetics now for 30 years and while I think we've seen exciting new developments and technology before, the Human Genome Project, the first cloning of disease genes, I think there has never been a time as exciting or as likely to change the field of clinical medical genetics as right now. It's a really exciting time to be a geneticist and to be leading this medical professional organization," Dr. Herman said.

As president elect, Dr. Herman has spent much of her time helping the ACMG develop guidelines and best practice policies and procedures to keep up with the pace of the evolving technologies engulfing the field of medical genetics.

"I'm very proud of the policy statements and guidelines the College already has put out, or has in progress, related to next gen sequencing," Dr. Herman said. "I think we are clearly at the forefront of recommendations and helping to define policy going forward. There is a lot more to do and I would certainly like to see that continue during my term as president."

Dr. Herman graduated summa cum laude from Smith College, Northampton, MA with high honors in chemistry. She then entered the NIH-funded Medical Scientist Training Program at Duke University where she received a PhD in Biochemistry and an MD.

She completed residency training in Pediatrics and a fellowship in Genetics at Baylor College of Medicine, Houston, TX. She received a prestigious Lucille P. Markey Scholar Award in 1987 and joined the faculty in the Institute for (subsequently Department of) Molecular and Human Genetics, Baylor College of Medicine in 1988 as an Assistant and then Associate Professor with tenure. She is board certified in Pediatrics and Clinical and Clinical Biochemical Genetics (lifetime certificates).

Dr. Herman joined the faculty of the Department of Pediatrics at Nationwide Children's Hospital and The Ohio State University in 1997 and was promoted to Professor with tenure in 2000. She served as Director of the Division and Center for Molecular and Human Genetics in the Department of Pediatrics from 1998-2009 where she substantially expanded clinical pediatric genetics services, including a comprehensive metabolic diagnostic and treatment program.

She divides her time between her clinical practice of pediatric genetics and basic molecular genetics research. She has had funding from the NIH, as well as past foundation funding from the March of Dimes and Muscular Dystrophy Association. She is an author on more than 100 peer-reviewed publications and is an internationally recognized expert on Disorders of Cholesterol Biosynthesis.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs